PE

Peter Emtage

CEO Santa Ana Bio, Inc.

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Clinical Development
Biochemistry
Infectious Diseases
Cell Culture
GLP
Drug Discovery
GMP
Clinical Research
FDA
Antibodies
Vaccines
Pharmacology
Biologics
Biotherapeutics
Assay Development
Inflammation
Autoimmunity
Oncology
Biomarker Discovery
Biotechnology

Investments

Santa Ana Bio

Series A

Total Funding: $170M

Work Experience

Santa Ana Bio, Inc

2021

  • Chief Executive Officer

    2021

Versant Ventures

2020

  • Venture Partner

    2020

Kite Pharma

2018 - 2020

  • Global Head of Cell Therapy Research

    2018 - 2020

Cell Design Labs

2016 - 2018

  • Chief Scientific Officer

    2016 - 2018

    Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies for cancer and other devastating diseases. Cell Design Labs leverages the power of the body’s immune system to develop smart, living therapies with the capability to treat our most challenging diseases with unprecedented power, precision, safety and durability.